Laugesen Christian, Ritschel Tobias, Ranjan Ajenthen G, Hsu Liana, Jørgensen John Bagterp, Svensson Jannet, Ekhlaspour Laya, Buckingham Bruce, Nørgaard Kirsten
Clinical Research, Steno Diabetes Center Copenhagen, Herlev, Denmark.
Division of Endocrinology and Diabetes, Department of Pediatrics, Stanford University, Stanford, California, USA.
Diabetes Technol Ther. 2024 Dec;26(12):897-907. doi: 10.1089/dia.2024.0022. Epub 2024 Jun 24.
To evaluate the impact of missed or late meal boluses (MLBs) on glycemic outcomes in children and adolescents with type 1 diabetes using automated insulin delivery (AID) systems. AID-treated (Tandem Control-IQ or Medtronic MiniMed 780G) children and adolescents (aged 6-21 years) from Stanford Medical Center and Steno Diabetes Center Copenhagen with ≥10 days of data were included in this two-center, binational, population-based, retrospective, 1-month cohort study. The primary outcome was the association between the number of algorithm-detected MLBs and time in target glucose range (TIR; 70-180 mg/dL). The study included 189 children and adolescents (48% females with a mean ± standard deviation age of 13 ± 4 years). Overall, the mean number of MLBs per day in the cohort was 2.2 ± 0.9. For each additional MLB per day, TIR decreased by 9.7% points (95% confidence interval [CI] 11.3; 8.1), and compared with the quartile with fewest MLBs (Q), the quartile with most (Q) had 22.9% less TIR (95% CI: 27.2; 18.6). The age-, sex-, and treatment modality-adjusted probability of achieving a TIR of >70% in Q was 1.4% compared with 74.8% in Q ( < 0.001). MLBs significantly impacted glycemic outcomes in AID-treated children and adolescents. The results emphasize the importance of maintaining a focus on bolus behavior to achieve a higher TIR and support the need for further research in technological or behavioral support tools to handle MLBs.
评估使用自动胰岛素输注(AID)系统时,漏餐或进餐延迟推注(MLB)对1型糖尿病儿童和青少年血糖结局的影响。本两项中心、跨国、基于人群的回顾性1个月队列研究纳入了来自斯坦福医疗中心和哥本哈根斯滕诺糖尿病中心、使用AID治疗(Tandem Control-IQ或美敦力MiniMed 780G)且有≥10天数据的6至21岁儿童和青少年。主要结局是算法检测到的MLB数量与目标血糖范围(TIR;70 - 180mg/dL)内时间之间的关联。该研究纳入了189名儿童和青少年(48%为女性,平均年龄±标准差为13±4岁)。总体而言,队列中每天的平均MLB数量为2.2±0.9。每天每增加一次MLB,TIR降低9.7个百分点(95%置信区间[CI] 11.3;8.1),与MLB最少的四分位数(Q₁)相比,MLB最多的四分位数(Q₄)的TIR低22.9%(95% CI:27.2;18.6)。在调整年龄、性别和治疗方式后,Q₁中TIR>70%的概率为1.4%,而Q₄中为74.8%(P<0.001)。MLB对接受AID治疗的儿童和青少年的血糖结局有显著影响。结果强调了持续关注推注行为以实现更高TIR的重要性,并支持对处理MLB的技术或行为支持工具进行进一步研究的必要性。